DESCRIBE <http://purl.uniprot.org/SHA-384/50B20986A82E52E980889072464CCA8EDFA71B43A5B25758AB7241F21073281199CF808221B9682A8A8193F2E96F2A8D>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/50B20986A82E52E980889072464CCA8EDFA71B43A5B25758AB7241F21073281199CF808221B9682A8A8193F2E96F2A8D	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/50B20986A82E52E980889072464CCA8EDFA71B43A5B25758AB7241F21073281199CF808221B9682A8A8193F2E96F2A8D	http://www.w3.org/2000/01/rdf-schema#comment	"This study suggests that polytransfused patients with SCA possessing the HLA-DQB1*03 and HLA-C*06 allele variants are more susceptible to alloimmunisation. In addition HLA-DRB1*04 and HLA-DRB1*11 alleles were seen to be associated with the production of anti-Fy(a) and anti-K antibodies respectively."xsd:string
http://purl.uniprot.org/uniprot/#_D6ABD4B9A717E28AD1C2B0B8DD55034C1684F6E5F430269237C35AC82DC2B4C93A283948AA0E4A1B35AF1B5A85BF6FD7	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/50B20986A82E52E980889072464CCA8EDFA71B43A5B25758AB7241F21073281199CF808221B9682A8A8193F2E96F2A8D
http://purl.uniprot.org/uniprot/L0BX47	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/50B20986A82E52E980889072464CCA8EDFA71B43A5B25758AB7241F21073281199CF808221B9682A8A8193F2E96F2A8D
http://purl.uniprot.org/uniprot/#_L0BX47-mappedCitation-28881103	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/50B20986A82E52E980889072464CCA8EDFA71B43A5B25758AB7241F21073281199CF808221B9682A8A8193F2E96F2A8D